| Application no. and date | 21795712.5 (espacenet) (Federated) (European Patent Register), 20210428 | | Patent/reg. no. and date | DK/EP 4143183, 20251022 | | Publication date | 20230308 | | Priority no. and date | WO PCT/CN2020/087776, 20200429, WO PCT/CN2020/105865, 20200730 | | EP pub. no. and date |
EP 4143183 20230308 | | Effective date | | | Applicant/owner | Gasherbrum Bio, Inc., 611 Gateway Blvd. Suite 223
South San Francisco, California 94080, US | | Applicant ref. no. | V499651DK00 | | Inventor | JENNINGS, Andrew,
San Francisco, California 94121, US,
LEI, Hui,
Shanghai 201210, CN,
LIN, Xichen,
Shanghai 201210, CN,
MENG, Qinghua,
Shanghai 201210, CN | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 31/496 (2006.01) , A61K 31/538 (2006.01) , A61P 3/10 (2006.01) , C07D 405/12 (2006.01) , C07D 405/14 (2006.01) , C07D 413/14 (2006.01) , C07D 471/04 (2006.01) | | Title | HETEROCYKLISKE GLP-1-AGONISTER | | Int. application no. | CN2021090645 | | Int. publication no. | WO2021219019 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
